Stocks · News reference
Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target
Wedbush analyst Michael Piccolo reiterates Staar Surgical (NASDAQ:STAA) with a Outperform and maintains $40 price target.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 4, 2026, 12:55 PM
- Checked
- Aug 4, 2026, 12:55 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $28
Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $31 to $28.
Read original at benzingaUBS Maintains Sell on Staar Surgical, Lowers Price Target to $19
UBS analyst Patrick Wood maintains Staar Surgical (NASDAQ:STAA) with a Sell and lowers the price target from $20 to $19.
Read original at benzingaWedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37
Wedbush analyst Michael Piccolo maintains Staar Surgical (NASDAQ:STAA) with a Outperform and lowers the price target from $40 to $37.
Read original at benzinga